Pancragen
A short bioregulator peptide studied mostly in Russian laboratory research related to the pancreas.
- Type
- Short peptide (bioregulator)
- Research area
- Bioregulator peptides
- Research stage
- Laboratory research; limited clinical use outside the U.S.
- FDA status
- Not an FDA-approved medicine
About Pancragen
A short bioregulator peptide studied mostly in Russian laboratory research related to the pancreas.
Where the research stands
Most published work on this compound comes from laboratory, animal or early human studies. Results in those settings don't always carry over to people, and long-term safety data are limited.
Read the studies
Educational information only; not medical advice. Talk to a licensed doctor before using any compound.
Common questions
Is Pancragen an FDA-approved medicine?
No. Pancragen is not an FDA-approved medicine. Research stage: Laboratory research; limited clinical use outside the U.S..
Does EKO Labs sell Pancragen?
No. EKO Labs does not sell Pancragen or any research compound. This library is for education only. EKO Labs offers FDA-approved prescription treatments only after a licensed doctor decides they are right for you.
Can people use Pancragen?
This page does not cover personal use. Products labeled "research use only" are not made or approved for people. Ask a licensed doctor before using any compound.
Related compounds
C15H26N6O8PinealonPinealon
A short bioregulator peptide studied mostly in Russian laboratory research related to nerve cells.
C20H33N5O9ProstamaxProstamax
A short bioregulator peptide studied mostly in Russian laboratory research related to prostate tissue.
TestagenTestagen
A short bioregulator peptide studied mostly in Russian laboratory research related to testicular tissue.